Synairgen plc Stock price

Equities

SNG

GB00B0381Z20

Biotechnology & Medical Research

Delayed London S.E. 07:30:51 2024-03-28 am EDT 5-day change 1st Jan Change
4.75 GBX -7.41% Intraday chart for Synairgen plc -4.94% -20.50%
Sales 2023 * - Sales 2024 * - Capitalization 10.33M 13.04M
Net income 2023 * -9M -11.36M Net income 2024 * - EV / Sales 2023 * -
Net Debt 2023 * 650K 820K Net Debt 2024 * 5.5M 6.94M EV / Sales 2024 * -
P/E ratio 2023 *
-1.07 x
P/E ratio 2024 *
-
Employees 34
Yield 2023 *
117%
Yield 2024 *
136%
Free-Float 96.68%
More Fundamentals * Assessed data
Dynamic Chart
1 day-7.41%
1 week-4.94%
Current month-3.59%
1 month-5.42%
3 months-22.51%
6 months-35.37%
Current year-20.50%
More quotes
1 week
4.00
Extreme 4
5.99
1 month
4.00
Extreme 4
6.60
Current year
4.00
Extreme 4
6.96
1 year
4.00
Extreme 4
17.50
3 years
4.00
Extreme 4
223.80
5 years
4.00
Extreme 4
260.00
10 years
4.00
Extreme 4
260.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 03-10-31
Director of Finance/CFO 43 Nov. 05
Chief Tech/Sci/R&D Officer - 23-10-02
Members of the board TitleAgeSince
Chairman 59 03-05-31
Founder 77 03-05-31
Chief Executive Officer 57 03-10-31
More insiders
Date Price Change Volume
24-03-28 4.75 -7.41% 18 838
24-03-27 5.13 -0.77% 305,261
24-03-26 5.17 +3.50% 200,284
24-03-25 4.995 -5.70% 770,995
24-03-22 5.297 +6.00% 335,662

Delayed Quote London S.E., March 28, 2024 at 07:30 am EDT

More quotes
Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company; Synairgen Inc. and Synairgen Research (Ireland) Limited. The Company is developing SNG001, an investigative formulation of inhaled interferon beta (IFN-B), for the treatment and prevention of various viral lung infections in high-risk patient groups. The Company has developed and is testing an inhaled formulation of IFN-B designed to directly target the lungs, the primary site of many viral lung infections, including COVID-19.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0513 GBP
Average target price
0.4 GBP
Spread / Average Target
+679.73%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Synairgen plc - London S.E.